Search alternatives:
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 521 - 540 results of 28,989 for search '(( 50 ((n decrease) OR (a decrease)) ) OR ( 5 ((mg decrease) OR (mean decrease)) ))', query time: 0.89s Refine Results
  1. 521
    HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis.

    HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 522
    Compound 390 induces HBV capsid accumulation via an ROS-mediated mechanism.

    Compound 390 induces HBV capsid accumulation via an ROS-mediated mechanism. by Daniel P. Bradley (10306893)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 523
    1466 does not change total yield of capsids during biochemical assembly reactions.

    1466 does not change total yield of capsids during biochemical assembly reactions. by Daniel P. Bradley (10306893)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 524
    1466 slows the capsid assembly rate in biochemical Cp149 capsid assembly reactions.

    1466 slows the capsid assembly rate in biochemical Cp149 capsid assembly reactions. by Daniel P. Bradley (10306893)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 525
    1466 inhibits capsid accumulation independent of HBV replication.

    1466 inhibits capsid accumulation independent of HBV replication. by Daniel P. Bradley (10306893)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 526
    Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein.

    Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 527
    αHT compound 390 does not affect intracellular capsid accumulation or encapsidated HBV RNA levels in HepG2.2.15 cells.

    αHT compound 390 does not affect intracellular capsid accumulation or encapsidated HBV RNA levels in HepG2.2.15 cells. by Daniel P. Bradley (10306893)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 528
    Compound structures and preferential inhibition of the HBV plus-polarity DNA strand.

    Compound structures and preferential inhibition of the HBV plus-polarity DNA strand. by Daniel P. Bradley (10306893)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 529
    S1 Data -

    S1 Data - by Oksana Boyarchuk (8910488)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 530
    Baseline characteristics of the patients with DM.

    Baseline characteristics of the patients with DM. by Oksana Boyarchuk (8910488)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 531
    Clinical and laboratory data of patients with DM and SIgAD.

    Clinical and laboratory data of patients with DM and SIgAD. by Oksana Boyarchuk (8910488)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 532
    The main laboratory findings in patients with DM and SIgAD.

    The main laboratory findings in patients with DM and SIgAD. by Oksana Boyarchuk (8910488)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 533
    Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L<sup>-1</sup>).

    Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L<sup>-1</sup>... by Sandra Thalerová (11434762)

    Published 2024
    Save to List
    Saved in:
  14. 534
    IFNγ enhances the Ser/5-HT-promoted <i>Trypanosoma cruzi</i> uptake by the human U-87 MG astroglioma cells.

    IFNγ enhances the Ser/5-HT-promoted <i>Trypanosoma cruzi</i> uptake by the human U-87 MG astroglioma cells. by Glaucia Vilar-Pereira (686134)

    Published 2024
    Save to List
    Saved in:
  15. 535
    Fx treatment abrogates the Ser/5-HT-promoted <i>Trypanosoma cruzi</i> infection of human U-87 MG astroglioma cells.

    Fx treatment abrogates the Ser/5-HT-promoted <i>Trypanosoma cruzi</i> infection of human U-87 MG astroglioma cells. by Glaucia Vilar-Pereira (686134)

    Published 2024
    Save to List
    Saved in:
  16. 536
    Deciphering the Inhibition of Ethane on Anaerobic Ammonium Oxidation

    Deciphering the Inhibition of Ethane on Anaerobic Ammonium Oxidation by Xin Tan (721363)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 537
    Mean productivity change in all 5 countries.

    Mean productivity change in all 5 countries. by Wasi Ul Hassan Shah (8605236)

    Published 2022
    Save to List
    Saved in:
  18. 538
    FTY720 potentiated the activity of cisplatin.

    FTY720 potentiated the activity of cisplatin. by Laura L. Stafman (6577184)

    Published 2019
    Save to List
    Saved in:
  19. 539
    Overexpression of miR-132-3p inhibits the TGF-<i>β</i>1/Smad2/3 signaling pathway in TGF-<i>β</i>1 induced MET-5A cells.

    Overexpression of miR-132-3p inhibits the TGF-<i>β</i>1/Smad2/3 signaling pathway in TGF-<i>β</i>1 induced MET-5A cells. by Yangyang Yin (14323701)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 540
    Cumulative distribution of EQ-5D-3L utilities decreasingly ordered before and after the onset of cutaneous leishmaniasis symptoms.

    Cumulative distribution of EQ-5D-3L utilities decreasingly ordered before and after the onset of cutaneous leishmaniasis symptoms. by Janaína de Pina Carvalho (12152812)

    Published 2025
    Save to List
    Saved in:

Search Tools: